The renowned biotechnology company Moderna said on Friday (August 26) that it is suing rival vaccine makers Pfizer and BioNTech. The American pharmaceutical company alleged that Pfizer and BioNTech infringed "patents central to (its) mRNA technology platform".

Moderna sues Pfizer and BioNTech for COVID-19 vaccine patent infringement

The Pfizer-BioNTech vaccine was authorised for children under 5 years of age in June, based on data that showed the vaccine generated a similar immune response as in older age groups.

Pfizer's Covid vaccine 73.2% effective in kids under 5, shows new data

American drugmaker Pfizer announced a deal on Monday to acquire Global Blood Therapeutics, makers of a recently approved treatment for sickle cell disease, for $5.

Pfizer to acquire sickle cell drugmaker GBT for $5 bn

The Joe Biden administration in the US has halted its plans of inoculating individuals younger than 50 with the second booster shots. Instead, the resources will be directed to accelerate a fall vaccination campaign where reformulated vaccines from Pfizer and Moderna will be used to jab the populace, in order to protect it from the most contagious strain of the virus - the omicron subvariant BA.

Biden administration to roll out updated Covid jabs after halting booster doses

Pfizer and BioNTech said that the updated version of their COVID-19 vaccine has shown a higher immune response against the Omicron variant. According to the statement, which was released on Saturday, the booster shot which was modified specifically to combat the variant has been showing better results.

Pfizer says updated COVID-19 shots boost protection against Omicron

The United States has approved Pfizer and Moderna coronavirus (COVID-19) vaccines for children as young as six months. The US Food and Drug Administration granted emergency authorisation Friday (June 17) for the use of Pfizer and Moderna jabs in the youngest children.

COVID-19: US approves Pfizer and Moderna jabs for kids as young as 6 months

On June 15, Pfizer announced that research found that Paxlovid, a COVID-19 tablet, did not significantly reduce the risk of hospitalisation or death in people with a typical risk of acquiring serious infections.

Pfizer says the Covid pill is not beneficial for standard-risk patients

Staff reviewers of US Food and Drug Administration (FDA) said on Sunday that Pfizer-BioNTech's COVID vaccines were safe and effective for children from ages 6 months to 4 years.

Pfizer COVID vaccines are safe for small children, says FDA staff

American multinational pharmaceutical Pzifer completed its emergency use application to the United States Food and Drug Administration (FDA) to administer its COVID-19 vaccine to children under the age of 5 on Wednesday.

Pfizer applies to FDA for covid vaccine approval for children under five

In a bid to make its medical products more accessible, US pharma giant Pfizer Inc. has decided to sell nearly two dozen patent-protected medicines and vaccines at not-for-profit prices to 45 low-income countries, the Wall Street Journal has reported.

Amid criticism of Covid profiteering, Pfizer to sell vaccines, drugs at lower prices to poor nations

Pfizer has said that the three-dose vaccine created by them has shown 80 per cent effectiveness against the Omicron COVID-19 infection among children aged between six months and five years.

Pfizer 3-dose COVID-19 vaccine 80 per cent effective in kids aged under five

The United States has approved Pfizer's booster shots for the 5-11 age group against COVID-19. The decision comes at a time when COVID-19 cases are increasing in the US.

The US approves Pfizer booster shots for the 5-11 age group against COVID-19

US drugmaker Pfizer reported a net income of $7.86 billion due to the COVID-19 vaccine and the Paxlovid pill. The vaccine helped the drugmaker to report $13 billion in sales in the quarter as the Paxlovid pill brought in $1.

Pfizer reports record profits amid growth in vaccine, Paxlovid pill

The World Health Organization (WHO) on Friday "strongly recommended" Pfizer’s COVID-19 antiviral pill Paxlovid for patients who have milder forms of the disease but are still at a high risk of hospitalisation, reports AFP.

Pfizer's anti-Covid pill gets WHO approval. Here's what you should know about Paxlovid

A COVID-19 vaccine developed specifically for the Omicron variant has been approved for clinical trials on Saturday (April 16). A Sinopharm and Sinovac subsidiary called China National Biotec Group (CNBG) has developed the vaccine.

Sinopharm, Sinovac vaccine candidates for Omicron variant get clearance for clinical trial

According to a US Fed Report, the government paid $1 Billion to American media to promote COVID-19 vaccines. Pfizer vaccine data reveals side effects.

US Fed Report: Government paid $1 Billion to American media to promote COVID-19 vaccines

The European medicines agency said that it has authorised Moderna's coronavirus vaccine for children aged six to 11. This comes in addition to recommending booster shots of Pfizer's vaccine for people aged 12 and over.

EU authorises Moderna vaccine for young kids; recommends Pfizer's booster

India’s Covid inoculation programme is largely driven by Indian made vaccines. Even though Russia’s Sputnik and Johnson & Johnson's single-dose vaccine were given a go-ahead by the Indian drug regulatory authority, it was Indian made Covaxin and Covishield that was widely used under the government-run vaccine programme.

Why were Pfizer and Moderna vaccines not available in India? Health minister responds

US health regulators delayed the review of Pfizer Inc's COVID-19 vaccine for children under 5 years of age because its two-dose regimen did not work well against the Omicron variant, the Wall Street Journal reported on Friday.

Low Omicron efficacy behind delay of Pfizer COVID vaccine for kids under 5: WSJ

A new study by the US Centers of Disease Control and Prevention (CDC) has said that the efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration.

Efficacy of Pfizer and Moderna vaccines wane after third dose: Study

In 2021, Pfizer's annual profits were more than double what they were in 2020. The company brought in $22 billion in profits in 2020. Vaccine sales accounted for 36.

Vaccine maker Pfizer faces accusations of 'pandemic profiteering' as profits double

Pfizer and BioNTech announced on Tuesday that they have begun a study comparing their Omicron-based Covid-19 vaccine against the original vaccine. If regulators decide to wait for the results of such a study, it might be months before an Omicron-specific vaccination becomes accessible.

COVID-19: Pfizer and BioNTech begin clinical trial of Omicron-based vaccine

A latest preliminary study has revealed that Russia's Covid vaccine, Sputnik V, shows higher Omicron-antibody levels than the Pfizer Covid vaccine. The joint Russian-Italian study was conducted by scientists from the Spallanzani Institute in Italy and Gamaleya Institute in Moscow, which also happens to be the developer of the Sputnik V vaccine.

Sputnik V shows higher Omicron-antibody levels than Pfizer: Study

Amid a rise in the coronavirus (COVID-19) cases globally after the emergence of the Omicron variant, experts and medical scientists are working to investigate the immune escape potential.

COVID-19: Fourth dose of vaccine 'not good enough' against Omicron variant, reveals Israeli study

pfizer

Pfizer, News on Pfizer, stories on Pfizer, articles on Pfizer, Pfizer stories at Wion, Pfizer news, Pfizer latest news